Facebook, GSK and Pfizer, Naspers and Tencent: CEO Daily for March 22, 2018 | Fortune

Top News
GSK and Pfizer
GlaxoSmithKline has beaten a rival bid from Reckitt Benckiser for Pfizer’s healthcare business, according to a Financial Times report. The business, which includes products such as Advil painkillers and Centrum multivitamins, may be worth up to $20 billion, Pfizer hopes. It’s not clear if there were other bidders. GSK shares rose on the news, while Reckitt’s fell. FT
Naspers and Tencent
South Africa’s Naspers is selling 6% of its stake in the Chinese tech giant Tencen…

Original Source